論文・技術情報追加のお知らせ

①Renal Disorders with Oral Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: An Analysis from the FDA Adverse Event Reporting System Database.

転移性大腸癌患者における、経口チロシンキナーゼ阻害薬による腎臓関連の有害事象評価研究

対象DB：FAERS

②Severe cutaneous adverse reactions associated with immune checkpoint inhibitors therapy and anti-VEGF combination therapy: a real-world study of the FDA adverse event reporting system.

免疫チェックポイント阻害薬と抗VEGF薬の併用療法による重篤な皮膚有害事象調査研究

対象DB：FAERS

③A pharmacovigilance study of the association between antipsychotic drugs and venous thromboembolism based on Food and Drug Administration adverse event reporting system data.

抗精神病薬と静脈血栓塞栓症との関連性調査研究

対象DB：FAERS

④Pregnancy-related Adverse Events associated with statins: A Real-World Pharmacovigilance study of the FDA Adverse Event Reporting System (FAERS).

スタチンの妊娠関連有害事象リスク調査研究

対象DB：FAERS

⑤Post-marketing safety of anti-IL-5 monoclonal antibodies (mAbs): an analysis of the FDA adverse Event Reporting System (FAERS).

抗IL-5モノクローナル抗体の安全性調査研究

対象DB：FAERS

⑥Safety profile of paediatric COVID-19 vaccines: An analysis of the US Vaccine Adverse Event Reporting System.

小児におけるCOVID-19ワクチンの安全性評価研究

対象DB：VAERS

⑦Profiles and Outcomes of Skin Injuries Caused by Injectable Drug Extravasation: An Analysis of the Japanese Adverse Drug Event Report Database.

血管外浸潤による皮膚有害事象リスク、転帰調査研究

対象DB：JADER

⑧Hepatobiliary Adverse Reactions during Treatment with Cladribine: Analysis of Data from the European Spontaneous Reporting System.

クラドリビンによる肝臓、胆道系有害事象調査研究

対象DB：EudraVigilance